FDA Investigator Mary T Carden
Mary T Carden has conducted inspections on 34 sites in 4 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
34
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada,
France,
Netherlands
FDA Investigators that have inspected at least one site in common with Mary T Carden:
Abby Lmozeke Baker,
Alice C Silva,
Althea A Williams,
Amanda B Athey,
Amy A Johnson,
Amy Kim,
Ana S Cabrera,
Angel K Sandhu,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie Bodnar,
Annette Melendez,
Anthony E Keller, RPh,
Anthony N Onianwa,
Barbara A Gullick,
Brandon L Mariner,
Brandy D Brown,
Brent W Higgs,
Brentley S Collins,
Brian A Graves,
Brian S Lynch,
Burnell M Henry,
Bush,
Byungja E Marciante,
Camilla S Smith,
Cara M Minelli,
Carl A Huffman, III,
Charles D Boison,
Charles N Dupont,
Cherlita A Honeycutt,
Cheryl L Watson,
Christian D Lynch (CDL),
Christina V Santos,
Christopher D Leach,
Christopher J Adams,
Cody D Rickman,
Cordelia J Brammer,
Creighton T Tuzon,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Daniel Pst Laurent,
Danielle R Rainey,
David R Heiar,
Dawn L Wydner,
Deborah Kleinfeld,
Deborah S Hammond,
Dellarese L Herbert,
Dennis M Farley,
Edward A Brunt,
Eileen J Bannerman,
Ellen P Madigan,
Emily B Camire,
Ernest H Blackwood,
Esra Toussaint,
Evelyn Taha,
Gail L Katz,
Garciam,
Gene D Arcy,
George C Amedro,
George J Flynn,
Gerald Mierle,
Gerald N Mcgirl, DDS,
Ginger M Sykes,
Harry J Brewer,
Heath R Harley,
Helen B Ricalde,
Helen J Hamaoka,
Henry E Sanchez,
Herbert E Arden,
Herminio C Francisco,
Hoimay Chan,
Holly S Simms,
Hristu B Chepa,
Irina Gaberman,
J David Doleski,
Jacqueline Mdiaz Albertini,
James R Montero,
James T Mccoy,
Jean M Kelahan,
Jeanette L Mcginnis,
Jeanne D Shaffer,
Jennifer A Jones,
Jennifer L Jager,
Jennifer L Sheehan,
Jennifer Macmillan,
Jessie E Morris,
Joan A Loreng,
Joanne Pryzbylik,
John Cook,
Judy C Nepsa,
Judy Ellen Ciaraldi,
Julie D Bringger,
Karan L Blum,
Karen Gale Sego,
Karen J Bak,
Karen L Kosar,
Kelly D Moore,
Kelly I Anderson,
Kenneth L Smalls,
Kenneth R Merritt,
Kent A Conforti,
Kimberley A Ricketts,
Kimberly Cdelk Brooks,
Kimberly M Bigler,
Kip J Hanks,
Kyson X Chou,
La Tasham Gunter,
Lakecha N Lewis,
Laressa R Gray,
Laura L Staples,
Lauren E Blaser,
Lauren E Swantko,
Laurie A Haxel,
Laurissa S Flowers,
Laverne Puckett,
LCDR Debra Emerson,
LCDR Jennifer H Rhyu,
LCDR Wilfred A Darang,
Leslie W Gilbert,
Linda M Sacco,
Linda S Mattingly,
Lorayne A Mcguinness,
Lucas B Leake,
Lynn L Wong,
Marc A Jackson, Jr,
Margaret Torres Vazquez,
Marion Michaelis,
Marion W Nadeau,
Mariza M Jafary,
Marla A Cassidy,
Marlene L Davis,
Martha T Olone,
Mary Ewilkerson Brinsko,
Meihong Liu,
Melinda K Plaisier,
Melissa D Kalik,
Michael E Maselli,
Michael W Burd,
Michelle D Haamid,
Nancy L Meade,
Nancy L Neiger,
Nancy L Rose,
Nathan R Moon,
Nicholas M Smith,
Normica G Facey,
Omotunde O Osunsanmi,
Patricia A Clark,
Patricia A Morrow,
Paula A Trost,
Paula J Bretz,
Prabhu P Raju,
Qiao Y Bobo,
Ralph A Erickson,
Randy L Clarida,
Randy V Bong,
Rebecca T Davis,
Richard D Manney,
Richard J Bashay,
Richard L Garcia,
Robert Jennings,
Robert S Sweeton,
Roger D Gawne,
Rose Ashley,
Sarah A Hassas,
Sarah Forney,
Sean R Moynihan, MPH,
Shelley H Beausoleil,
Sherry L Secrist, BLT DO,
Sherry M Nisson,
Sheryl A Kochman,
Shusheen A Alexander,
Simone E Pitts,
Stephany J Wesley,
Stephen D Brown,
Stephen R King,
Stephen T Hansen,
Sunitha K Rajaram, PhD,
Sylvia A Craven,
Tammy S Notto,
Tania Y Hall,
Teena H Aiken,
Teresita C Mercado,
Timothy P Lafave,
Traci M Armand,
Tracy R Ball,
Trushani T Desai,
Victoria V Bot,
Wanda Y Honeyblue,
William C Lubas,
William F Lagud, Jr,
William J Foust
Mary T Carden's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2009 | FDA 483 | Windsor Quality Foods Co - Form 483, 2009-05-27 |
January, 2000 | FDA 483 | American National Red Cross (the) - Form 483, 2000-01-25 |
September, 2003 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2003-09-25 |
December, 2002 | FDA 483 | American Red Cross National Headquarters - Form 483, 2002-12-20 |
April, 2000 | FDA 483 | American Red Cross National Headquarters - Form 483, 2000-04-26 |
January, 2002 | EIR | Johane Allard, M.D. - EIR, 2002-01-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more